Cbfβ reduces Cbfβ-SMMHC-associated acute myeloid leukemia in mice

Cancer Research

Volumn 66, Issue 23, 2006, Pages 11214-11218

  Heilman, Susan A ^a   Kuo, Ya Huei ^a   Goudswaard, Chantal S ^b   Valk, Peter J ^b   Castilla, Lucio H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR BETA; HYBRID PROTEIN; PROTEIN SMMHC; UNCLASSIFIED DRUG; CBFB PROTEIN, HUMAN; CBFB PROTEIN, MOUSE; CBFBETA MYH11 FUSION PROTEIN; CBFBETA-MYH11 FUSION PROTEIN; MYOSIN HEAVY CHAIN; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ACUTE DISEASE; ANIMAL; CHEMISTRY; CHROMOSOME 16; CHROMOSOME INVERSION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; KAPLAN MEIER METHOD; METABOLISM; MUTATION; MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; PATHOLOGY; SMOOTH MUSCLE; TRANSGENIC MOUSE;

ACUTE DISEASE; ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 16; CORE BINDING FACTOR BETA SUBUNIT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; INVERSION, CHROMOSOME; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOID; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH; MUTATION; MYELOID PROGENITOR CELLS; MYOSIN HEAVY CHAINS; ONCOGENE PROTEINS, FUSION;

EID: 33845729385     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0959     Document Type: Article

References (21)

1. Reilly JT. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis? Br J Haematol 2005;128:18-34.
2. Otto F, Lubbert M, Stock M. Upstream and downstream targets of RUNX proteins. J Cell Biochem 2003;89:9-18.
3. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A 1996;93:3444-9.
4. Wang Q, Stacy T, Miller JD, et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 1996;87:697-708.
5. Sasaki K, Yagi H, Bronson RT, et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β. Proc Natl Acad Sci U S A 1996;93:12359-63.
6. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996;84:321-30.
7. Miller J, Horner A, Stacy T, et al. The core-binding factor β subunit is required for bone formation and hematopoietic maturation. Nat Genet 2002;32:645-9.
8. Yoshida CA, Furuichi T, Fujita T, et al. Core-binding factor β interacts with Runx2 and is required for skeletal development. Nat Genet 2002;32:633-8.
9. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997;278:1059-64.
10. Liu P, Tarle SA, Hajra A, et al. Fusion between transcription factor CBF β/PEBP2 β and a myosin heavy chain in acute myeloid leukemia. Science 1993;261:1041-4.
11. Castilla LH, Wijmenga C, Wang Q, et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 1996;87:687-96.
12. Kuo YH, Landrette SF, Heilman SA, et al. Cbfβ-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell 2006;9:57-68.
13. Growney JD, Shigematsu H, Li Z, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005;106:494-504.
14. Ichikawa M, Asai T, Saito T, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004;10:299-304.
15. Miller JD, Stacy T, Liu PP, Speck NA. Core-binding factor β (CBFβ), but not CBFβ-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFβ-deficient embryonic stem cells. Blood 2001;97:2248-56.
16. Castilla LH, Garrett L, Adya N, et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet 1999;23:144-6.
17. Castilla LH, Perrat P, Martinez NJ, et al. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc Natl Acad Sci U S A 2004;101:4924-9.
18. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995;269:1427-9.
19. Landrette SF, Kuo YH, Hensen K, et al. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 2005;105:2900-7.
20. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004;350:1617-28.
21. Chan IT, Kutok JL, Williams IR, et al. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 2004;113:528-38.